The Global COVID-19 Treatment Market is analysed to grow at a substantial growth rate during the forecast period 2019-2026. The global market analysis includes the study of all measures that are considered by the healthcare professionals to contain and treat the COVID-19.
The global market is driven by sudden outbreak of COVID-19 in China that further spread to other parts of the globe rapidly. According to the World Health Organization, COVID-19 has spread to over 209 countries and territories with over 1,431,750 confirmed cases and over 82,080 deaths as of 8th April 2020.
The global governments are actively responding to the threat and future impact of COVID-19 with all the crucial measures such as large-scale quarantines, travel restrictions, nationwide lockdown and social distancing that will negatively impact the consumer spending and businesses and will influence the economic conditions of the countries.
Segmentation Overview of the Global COVID-19 Treatment Market
The Global Covid-19 Treatment Market is analysed for different market segments and their sub-segments for an insightful market analysis and results. The major categorization of the global market is on the basis of Type and Application.
The Type Segments is further segmented into Treatment Type and Severity Degree.
The Treatment Segment is further categorised into Respiratory Support, Circulatory Support, Convalescent Plasma Therapy, Antiviral Medicine (a-interferon, lopinavir/ritonavir, ribavirin), Antimicrobial Therapy, Renal Failure and Renal Replacement Therapy, Lung Replacement Therapy, Immunotherapy and Other therapeutic measures.
The Severity Degree Segment is further categorised into Light, Ordinary, Heavy, Critical and Convalescence.
The Application Segment is further segmented into Children, Adult, Special Groups such as Pregnant Women and Others.
Geographical Overview of the Global COVID-19 Treatment Market
The geographical segmentation of the global COVID-19 treatment market include study across North America, Europe, Latin America, Asia Pacific, and Middle East & Africa (MEA). As per the market study, the North American market is dominating the global market, owing to continuous growth in number of COVID-19 cases in the United States which require rapid testing in the near future to contain the spread of disease in the region. On the other hand, the Asia-Pacific is expected to grow at fastest CAGR during the forecast period, owing to large scale of population base in the countries such as India and China.
Key Players Insights
The Global COVID-19 Treatment market research study include profiling and study of various companies that are directly impacting the global market. Some of the major players included in the research study are listed below, such as:
Clover Biopharmaceuticals
ExpreS2ion Biotechnologies ApS
CanSino Biologics, Inc.
Greffex Inc.
Altimmune
Janssen Pharmaceuticals
Ascletis Pharma
Bravovax
Novavax
Moderna Therapeutics
Generex Biotechnology Corporation
MIGAL Galilee Research Institute
Zydus Cadila
Evvivax
Takis Biotech
GeoVax Labs, Inc.
Codagenix and Sciences, Inc.
The market players are adopting strategies to withhold this niche market for the next few years. As COVID-19 is highly contagious and impacting the health and economies of countries, hence researchers are aggressively working on novel medications and vaccines to contain this disease. Therefore, the global COVID-19 treatment market is analysed to have positive impact for the few years and is expected to have steep curve in the in the late years of forecast period.
